RayzeBio, Inc. Common Stock
RayzeBio, Inc. Common Stock (RYZB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RYZB · as of Jun 8, 2026
Key Statistics
Explore RayzeBio, Inc. Common Stock Data
ryzb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
ryzb competitorsRYZB
ALPN
CBAY
KDNY
MOR
MORFStock Performance
Full HistoryAbout RayzeBio, Inc. Common Stock
RayzeBio, Inc. Common Stock RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trial…
what is rayzebio, inc. common stock · ryzb stock overview · rayzebio, inc. common stock company profile · who is rayzebio, inc. common stock ceo · ryzb NASDAQ · rayzebio, inc. common stock headquarters · rayzebio, inc. common stock business segments
About Stock Overview & Key Data
RayzeBio, Inc. Common Stock (RYZB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2023. As of the latest trading session, RYZB stock price is $62.49, with a market capitalization of $3.8B. The stock has returned +160.38% over the past 12 months and +0.87% year-to-date.
According to 1 Wall Street analysts, the consensus rating for RayzeBio, Inc. Common Stock stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, RayzeBio, Inc. Common Stock reported revenue of — and net income of -$68.6M. For detailed data — including RayzeBio, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, RayzeBio, Inc. Common Stock (RYZB) stock price is $62.49. The stock is traded on NASDAQ under the ticker symbol RYZB. The 52-week range is $17.95 – $62.51.